BDBM102351 US10562854, No. F2::US8536181, F2::US9278930, F2

SMILES Oc1cccn(Cc2cccc(Cl)c2)c1=O

InChI Key InChIKey=VIWSANOEUHNZFR-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 102351   

TargetEgl nine homolog 1(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102351(US10562854, No. F2 | US8536181, F2 | US9278930, F2)
Affinity DataIC50:  5.00E+3nMAssay Description:EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEgl nine homolog 1(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102351(US10562854, No. F2 | US8536181, F2 | US9278930, F2)
Affinity DataIC50:  5.00E+3nMpH: 7.5Assay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetEgl nine homolog 1(Homo sapiens (Human))
Aerpio Therapeutics

US Patent
LigandPNGBDBM102351(US10562854, No. F2 | US8536181, F2 | US9278930, F2)
Affinity DataIC50:  5.00E+3nMAssay Description:The EGLN-1 (or EGLN-3) enzyme activity is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-T...More data for this Ligand-Target Pair
In DepthDetails US Patent